Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera.
1978 ◽
Vol 148
(3)
◽
pp. 776-786
◽
The present studies demonstrate that antisera directed against Streptococcus pneumoniae type 14 is opsonic for group B streptococci type III in a neutrophile-mediated bactericidal assay. Specificity was demonstrated by the observations that group B streptococci type III and S. pneumoniae type 14 adsorbed the opsonic activity of anti-S. pneumoniae type 14 antisera. Group B streptococci strain 090R (devoid of type antigens) and S. pneumoniae type 3, did not remove the opsonic activity of anti-S. pneumoniae type 14 serum. In vivo studies using a suckling rat model of neonatal group B streptococcal type III sepsis demonstrated that antisera directed against S. pneumoniae type 14 was highly protective.
1989 ◽
Vol 26
(4)
◽
pp. 383-387
◽
Keyword(s):
1999 ◽
Vol 86
(1)
◽
pp. 61-65
◽
Keyword(s):
1996 ◽
Vol 40
(6)
◽
pp. 1573-1574
◽
Use of chlorhexidine during labor: How effective against neonatal group B streptococci colonization?
1995 ◽
Vol 74
(2)
◽
pp. 168-168
◽